Case Report
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Dec 16, 2021; 9(35): 11078-11084
Published online Dec 16, 2021. doi: 10.12998/wjcc.v9.i35.11078
Double-mutant invasive mucinous adenocarcinoma of the lung in a 32-year-old male patient: A case report
Ting Wang
Ting Wang, Department of Respiratory Medicine, Xi’an People’s Hospital (The Fourth Xi’an Hospital), Xi’an 710049, Shannxi Province, China
Author contributions: Wang T is responsible for manuscript writing, data collection, and performing the analysis with constructive discussions.
Informed consent statement: Written consent to publish the clinical or possible personal information was obtained from the participant included in the study.
Conflict-of-interest statement: Dr. Wang has nothing to disclose.
CARE Checklist (2016) statement: The content of the article is consistent with CARE Checklist (2016) Statement.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ting Wang, PhD, Doctor, Department of Respiratory Medicine, Xi’an People’s Hospital (The Fourth Xi’an Hospital), No. 21 Jiefang Road, Xincheng District, Xi’an 710049, Shannxi Province, China. hdwt.ok@163.com
Received: June 24, 2021
Peer-review started: June 24, 2021
First decision: July 26, 2021
Revised: July 27, 2021
Accepted: September 15, 2021
Article in press: September 15, 2021
Published online: December 16, 2021
Processing time: 168 Days and 22.1 Hours
Abstract
BACKGROUND

Invasive mucinous adenocarcinoma of the lung, formerly known as mucinous bronchioloalveolar carcinoma, is a rare category of lung tumors and radiologically characterized by dense pneumonic consolidation, ground-glass opacity, crazy paving, and nodules. However, early pleural effusion is uncommon in this malignancy.

CASE SUMMARY

The case of a 32-year-old male patient who visited our facility with symptoms of cough and gradually aggravated shortness of breath was reported. X-ray examination revealed a massive left hydrothorax. The patient underwent thoracocentesis, and pleural fluid tumor markers, including carcinoembryonic antigen, carbohydrate antigen 19-9, neuron-specific enolase, and cytokeratin 21-1 fragment, were significantly elevated. A similar tendency was observed among the serum tumor markers. After draining the pleural effusion, the patient underwent chest computed tomography, and no obvious mass was found in the lung. Thoracoscopy revealed that the left visceral pleura was covered with nodular, cauliflower-like protrusions of various sizes. These histopathological results suggested cancerous cells, and the immunohistochemical findings were consistent with mucinous adenocarcinoma of pulmonary origin. It tested positive for cytokeratin, cytokeratin 5/6, carcinoembryonic antigen, and thyroid transcription factor-1.

CONCLUSION

The patient was diagnosed with a rare case of lung mucinous adenocarcinoma. Subsequent genetic testing was positive for epidermal growth factor receptor-21 mutations and echinoderm microtubule-associated protein-like 4-lymphoma anaplastic kinase fusion. This prompted treatment with alfatinib and crizotinib.

Keywords: Lung mucinous adenocarcinoma; Hydrothorax; Double mutant; Case report

Core tip: Invasive mucinous adenocarcinoma of the lung is a rare category of lung tumors, radiologically characterized by dense pneumonic consolidation, ground-glass opacity, crazy paving, and nodules. Early pleural effusion is uncommon in this malignancy. Molecularly, invasive mucinous adenocarcinoma has frequent Kirsten rat sarcoma viral oncogene mutations and a lower prevalence of epidermal growth factor receptor and anaplastic lymphoma kinase rearrangements. Here, a rare case of double-mutant invasive mucinous lung adenocarcinoma presenting as a massive malignant pleural effusion in a 32-year-old male patient was reported.